
Deepak R Rao
Examiner (ID: 6957, Phone: (571)272-0672 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1611, 1202, 1624 |
| Total Applications | 3005 |
| Issued Applications | 2150 |
| Pending Applications | 168 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7677112
[patent_doc_number] => 20040152714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Benzylaminopyrimidines'
[patent_app_type] => new
[patent_app_number] => 10/477622
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10074
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152714.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477622 | Benzylaminopyrimidines | Mar 22, 2004 | Issued |
Array
(
[id] => 7111803
[patent_doc_number] => 20050209259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Novel anhydrous amorphous forms of rosuvastatin calcium, pitavastatin calcium and fluvastatin sodium'
[patent_app_type] => utility
[patent_app_number] => 10/802585
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5642
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802585 | Anhydrous amorphous form of fluvastatin sodium | Mar 16, 2004 | Issued |
Array
(
[id] => 7672843
[patent_doc_number] => 20040180936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Heterocyclic compounds and their use as medicaments'
[patent_app_type] => new
[patent_app_number] => 10/803387
[patent_app_country] => US
[patent_app_date] => 2004-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15746
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10803387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/803387 | Heterocyclic compounds and their use as medicaments | Mar 15, 2004 | Abandoned |
Array
(
[id] => 5835410
[patent_doc_number] => 20060247241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => '2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders'
[patent_app_type] => utility
[patent_app_number] => 10/549250
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60309
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247241.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549250 | 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders | Mar 11, 2004 | Issued |
Array
(
[id] => 7447935
[patent_doc_number] => 20040186119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => '4-Substituted-5-cyano-1H-pyrimidin-6-(thi) ones as GSK-3 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/799507
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10041
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186119.pdf
[firstpage_image] =>[orig_patent_app_number] => 10799507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/799507 | 4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors | Mar 11, 2004 | Issued |
Array
(
[id] => 651008
[patent_doc_number] => 07112585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'Pyrimidine derivatives as corticotropin releasing factor inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/800241
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17701
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112585.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800241 | Pyrimidine derivatives as corticotropin releasing factor inhibitors | Mar 11, 2004 | Issued |
Array
(
[id] => 5096211
[patent_doc_number] => 20070117820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Heterocyclic urea derivatives for the treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 10/548260
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6747
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548260 | Heterocyclic urea derivatives for the treatment of pain | Mar 4, 2004 | Issued |
Array
(
[id] => 338158
[patent_doc_number] => 07504501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-17
[patent_title] => 'Antiprotozoal imidazopyridine compounds'
[patent_app_type] => utility
[patent_app_number] => 10/548154
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12643
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/504/07504501.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548154 | Antiprotozoal imidazopyridine compounds | Mar 1, 2004 | Issued |
Array
(
[id] => 7427077
[patent_doc_number] => 20040229858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'VLA-4 inhibitor compounds'
[patent_app_type] => new
[patent_app_number] => 10/787905
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 211083
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787905 | VLA-4 inhibitor compounds | Feb 25, 2004 | Issued |
Array
(
[id] => 7098771
[patent_doc_number] => 20050131230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Method and associated compounds for forming nanotubes'
[patent_app_type] => utility
[patent_app_number] => 10/784696
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18214
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10784696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/784696 | Method and associated compounds for forming nanotubes | Feb 22, 2004 | Abandoned |
Array
(
[id] => 7468622
[patent_doc_number] => 20040167135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Dihydropyrimidines'
[patent_app_type] => new
[patent_app_number] => 10/781075
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7499
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167135.pdf
[firstpage_image] =>[orig_patent_app_number] => 10781075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/781075 | Dihydropyrimidines | Feb 16, 2004 | Abandoned |
Array
(
[id] => 533157
[patent_doc_number] => 07179914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-20
[patent_title] => 'Process for the production of 4-alkylpyrimidine'
[patent_app_type] => utility
[patent_app_number] => 10/778254
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1981
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778254
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778254 | Process for the production of 4-alkylpyrimidine | Feb 16, 2004 | Issued |
Array
(
[id] => 7105412
[patent_doc_number] => 20050107414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Pyrimidine-2,4,6-trione metalloproteinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/778990
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25950
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107414.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778990 | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | Feb 12, 2004 | Abandoned |
Array
(
[id] => 543513
[patent_doc_number] => 07169798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases'
[patent_app_type] => utility
[patent_app_number] => 10/779532
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17603
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779532 | Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases | Feb 12, 2004 | Issued |
Array
(
[id] => 7466757
[patent_doc_number] => 20040198758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides'
[patent_app_type] => new
[patent_app_number] => 10/486398
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17478
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198758.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486398 | N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides | Feb 10, 2004 | Abandoned |
Array
(
[id] => 7241276
[patent_doc_number] => 20040158062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Process for the production of quinazolines'
[patent_app_type] => new
[patent_app_number] => 10/775001
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3621
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20040158062.pdf
[firstpage_image] =>[orig_patent_app_number] => 10775001
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/775001 | Process for the production of quinazolines | Feb 8, 2004 | Abandoned |
Array
(
[id] => 535750
[patent_doc_number] => 07176212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => '2,4-diamino pyrimidine compounds having anti-cell proliferative activity'
[patent_app_type] => utility
[patent_app_number] => 10/771118
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29862
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176212.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771118 | 2,4-diamino pyrimidine compounds having anti-cell proliferative activity | Feb 3, 2004 | Issued |
Array
(
[id] => 630453
[patent_doc_number] => 07132414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-07
[patent_title] => 'Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation'
[patent_app_type] => utility
[patent_app_number] => 10/771764
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13038
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/132/07132414.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771764 | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation | Feb 3, 2004 | Issued |
Array
(
[id] => 446532
[patent_doc_number] => 07253187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-07
[patent_title] => 'Heterocyclic inhibitors of ERK2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/770814
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30475
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/253/07253187.pdf
[firstpage_image] =>[orig_patent_app_number] => 10770814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/770814 | Heterocyclic inhibitors of ERK2 and uses thereof | Feb 2, 2004 | Issued |
Array
(
[id] => 7351753
[patent_doc_number] => 20040248884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/770382
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108751
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10770382
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/770382 | Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | Feb 1, 2004 | Issued |